NCT05636904View on ClinicalTrials.gov

Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 5, 2022

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions
Androgenetic Alopecia
Interventions
DRUG

prostaglandin F2a analogue in vehicle solution high dose

Topical treatment for 24 weeks

DRUG

prostaglandin F2a analogue in vehicle solution low dose

Topical treatment for 24 weeks

DRUG

active ingredient-free vehicle solution to DLQ01

Topical treatment for 24 weeks

DRUG

Minoxidil 5% Topical Solution

Topical treatment for 24 weeks

Trial Locations (2)

3002

Dr Rodney Sinclair Pty Ltd,, East Melbourne

3044

Dr Rodney Sinclair Pty Ltd,, Pascoe Vale South

Sponsors
All Listed Sponsors
lead

Dermaliq Therapeutics, Inc.

INDUSTRY